
Research Associate, Antibody Development
Our mission is to make biology easier to engineer. Ginkgo is constructing, editing, and redesigning the living world in order to answer the globe’s growing challenges in health, energy, food, materials, and more. Our bioengineers make use of an in-house automated foundry for designing and building new organisms.
We are seeking a highly motivated and detail-oriented Research Associate to join our Antibody Developability team. The successful candidate will contribute to the preclinical evaluation of therapeutic antibody candidates by performing in vitro and biophysical assays to assess key developability properties such as stability, aggregation propensity, solubility, viscosity, and expression. This position offers an exciting opportunity to work in a collaborative, interdisciplinary environment focused on advancing biologics from discovery to development.
Key Responsibilities:
- Perform routine procedures associated with the production, preparation, or characterization (e.g., SEC, DLS, DSF, UV/Vis, HIC) of antibodies for internal and customer projects.
- Maintain accurate and detailed electronic laboratory notebooks and experimental records.
- Present outcomes and observations from experiments to other subject matter experts.
- Support assay validation and transfer to internal and external partners as needed.
Qualifications:
- B.S. in Biochemistry, Molecular Biology, Biotechnology, or initial training in a lab-based environment.
- High degree of personal responsibility
- Strong organizational skills, attention to detail, and the ability to manage multiple tasks in a fast-paced environment.
- Excellent communication and teamwork skills.
Preferred:
- Experience working in a lab-based or highly operational environment.
- Experience with antibody or protein characterization in an industry or academic setting.
- Exposure to analytical instrumentation (e.g., UPLC, MALS, mass spectrometry) is a plus.
- What is it really like to take your company public via a SPAC? One Boston biotech shares its journey (Fortune)
- Ginkgo Bioworks resizes the definition of going big in biotech, raising $2.5B in a record SPAC deal that weighs in with a whopping $15B-plus valuation (Endpoints News)
- Ginkgo Bioworks CEO on scaling up Covid-19 testing: ‘If we try, we can win’ (CNBC)
- Ginkgo raises $70 million to ramp up COVID-19 testing for employers, universities (Boston Globe)
- Ginkgo Bioworks Redirects Its Biotech Platform to Coronavirus (Wall Street Journal)
- Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response (PRNewswire)
- The Life Factory: Synthetic Organisms From This $1.4 Billion Startup Will Revolutionize Manufacturing (Forbes)
- Synthetic Bio Pioneer Ginkgo Raises $290 Million in New Funding (Bloomberg)
- Ginkgo Bioworks raises $350 million fund for biotech spinouts (Reuters)
- Can This Company Convince You to Love GMOs? (The Atlantic)
Apply for this job
*
indicates a required field